LaserHear™ is a low-level light laser jointly developed by HearingMed and Erchonia Medical. Preliminary trial results document its revolutionary ability to: Enhance speech intelligibility for patients with sensorineural hearing loss. Moderate tinnitus symptoms in SNHL base tinnitus LaserHear™ is designed to generate light at the specific wave lengths known to enhance cellular metabolism. Research documents its ability to trigger the production of ATP (adenosine triphosphate), a metabolic process that excites cellular mitochondria into a healthier, better-functioning state. LaserHear™ uses a patented, pulsed, multi-diode red and green line-generated laser beam. All other lasers use a dot generated light source. LaserHear's™ line-generated beam greatly increases the surface area treatable in one procedure and drastically reduces required treatment time. LaserHear™ offers those suffering from sensorineural hearing loss and tinnitus a safe, non-invasive alternative to the current traditional means of combating these pervasive hearing health conditions. LaserHear™ Sensorineural Mechanism of Action and Initial Findings The mechanism of action with the LaserHear™ device on sensorineural hearing loss and word and speech recognition is multi-factorial. To better understand the mechanism of action it is important to understand the pathophysiology of sensorineural hearing loss. Sensorineural hearing loss accounts for about 90 percent of all hearing loss. Presbyacusis, or age related ...
